Direct Meds review

Direct Meds at a glance

Semaglutide

$297/mo for the injection, all-inclusive

Tirzepatide

$399/mo for the injection

Coverage

Not published; the Terms say only "states where we offer it"

Start

Approved within hours, ships in 1 business day

How we scored Direct Meds

Each factor is read off Direct Meds's published pricing, disclosures and intake flow, and the six roll up into the 75/100 Rx-Readiness Score on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.

What to expect when you sign up

We walked Direct Meds's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.

1. 1Take the online assessment — "Complete our secure online quiz and intake form—no appointments needed", so there is no camera visit to schedule
2. 2A licensed provider reviews it; the site says the prescription is "reviewed and approved within hours"
3. 3Medication "ships within 1 business day with free priority shipping", and the charge appears on your statement as "DM2*Directmeds"
4. 4Cancellation is the part to read twice: the marketing page promises "Cancel Anytime", and the Terms say prescription orders "generally cannot be canceled" more than 24 hours after you place them

HSA/FSA generally applies to GLP-1 telehealth; confirm with your plan. These figures are Direct Meds's public disclosures at last review and change often; confirm the current number on Direct Meds's own site.

Direct Meds, answered

How much does Direct Meds cost, and is anything extra added on?

Read live on 26 August 2026, its weight-loss page says "Plans start at $249/month for sublingual Semaglutide, and $297/month for injections," and describes the rate as all-inclusive — "everything from the medication itself to nurse support, shipping, and digital follow-ups is bundled into one clear monthly rate." It also says plainly: no monthly membership. That is a genuinely clean structure, and rarer than it should be. Two caveats. Both figures are a starting point and no dose ladder is published, so what you pay at a maintenance dose is not disclosed. And no tirzepatide price appears anywhere on the public site now, so if that is the molecule you want, get the number in writing first.

Direct Meds says "Cancel Anytime". Is that accurate?

Partly, and the gap is worth knowing. The weight-loss page prints "No Monthly Memberships / No Hidden Fees / Cancel Anytime" three separate times. Its Terms of Sale, which is the document you agree to at checkout, are narrower: you may attempt to cancel a prescription order within 24 hours of placing it, and after 24 hours prescription orders "generally cannot be canceled." A subscription can be stopped at any time, but there is no refund on medication already received, and a returned medication carries a $35 disposal fee. So the honest version is: the recurring plan is easy to leave, the individual order you have already placed usually is not. Read both before you pay.

Do I need a video visit with Direct Meds?

No. Its how-it-works page says "Complete our secure online quiz and intake form—no appointments needed," and there is no scheduled camera visit anywhere in the published flow. It says the prescription is reviewed and approved within hours and that medication ships within one business day with free priority shipping. For a mother whose only free half-hour is after bedtime, that is the single most useful thing about this provider — and it is why it scores well on speed here despite everything below.

What is the Direct Meds FDA warning letter about?

Warning letter #716822, dated 9 September 2025, was sent to directmeds.com, Inc. dba DirectMeds and names directmeds.com directly, so there is no name-collision doubt. The FDA reviewed the site in August 2025 and objected to three specific marketing sentences, all making the same move — for example, "Compounded semaglutide contains the same active ingredient as branded semaglutide." The FDA's position is that compounded drugs are not FDA-approved and that claims implying equivalence to an approved product are false or misleading, which makes the products misbranded. It is a marketing-language finding, not a safety finding about a specific batch. We list Direct Meds with the letter disclosed rather than quietly dropping it, because someone searching for it deserves to find it discussed.

Who actually compounds the medication, and where is the company?

Neither is answered on the public site as of 26 August 2026. No compounding pharmacy is named on any page we read — an earlier version of this record named two 503A partners, and those names no longer appear anywhere, so we have removed the claim rather than keep asserting it. The footer address is a private mailbox in Houston, Texas, while the FDA's 2025 letter went to a Bluffdale, Utah address and the Terms still name Utah law and Salt Lake City arbitration. What it does disclose well is people: thirteen named executives including a named Chief Medical Officer, Dr. Justin Hohl, which is more than most sellers on this list manage.

Is Direct Meds available in my state?

It does not say. Its Terms state only that "The Service is available only in states where we offer it," and no state list or exclusion list appears anywhere on the public site. An earlier check of this record recorded Mississippi, Louisiana and California as excluded; that could not be re-confirmed on 26 August 2026, so treat it as a lead rather than a fact and confirm your own state during signup. Given the cancellation terms, confirm those in the same message.

Does Direct Meds offer a no-needle option?

Yes. Its product catalog lists semaglutide and tirzepatide in both injection and sublingual (under-the-tongue) forms, and the sublingual semaglutide is the $249 starting price. Worth knowing before you pick it on convenience alone: sublingual delivery of these peptides is far less studied than the weekly injection the clinical trials actually used, so it is a convenience option rather than a proven equal. If needles are the obstacle, the FDA-approved oral tablets now on the market are a different and better-evidenced conversation.